Form 4: UiPath CEO Sells Shares Under 10b5-1 Plan

UiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $13.0057 per share under a pre-arranged 10b5-1 plan.

Summary

• Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported the sale of 122,733 shares of Class A Common Stock.
• The transaction occurred on October 3, 2025, at an average price of $13.0057 per share.
• The shares were sold in compliance with a qualified selling plan adopted by Mr. Dines pursuant to Rule 10b5-1.
• The price range for the transactions was from $12.7500 to $13.1300 per share.
• Following the reported transaction, Mr. Dines beneficially owns 29,918,585 shares directly and 1,104,604 shares indirectly through Ice Vulcan Holding Limited, where he retains sole voting and investment power.
• An additional 240,000 shares are indirectly beneficially owned by his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling, making it a routine disclosure.

Positives

• The sale was executed under a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary transaction, which typically mitigates concerns about opportunistic insider selling.

Negatives

• CEO Daniel Dines sold 122,733 shares of Class A Common Stock, which some investors may interpret as a reduction in insider confidence, despite being executed under a pre-arranged 10b5-1 plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape. It is specific to the personal stock holdings and transactions of a key executive.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned under a Rule 10b5-1 plan, reducing concerns of opportunistic selling and not indicating a change in company fundamentals.

Key Dates

Recommendation

The reported transaction is a pre-planned sale by the CEO under a Rule 10b5-1 plan. Such routine insider sales typically do not reflect a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

UiPath, PATH, Daniel Dines, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, CEO